|
|
|
Volumn 147, Issue 42, 2005, Pages 32-36
|
|
The metabolic syndrome and mental illness: Relevance, risk factors and practical consequences;Metabolisches syndrom und psychische erkrankungen: Relevanz, risikofaktoren und praktische konsequenzen
|
|
Author keywords
Atypical neuroleptics; Major depression; Metabolic syndrome; Schizophrenia
|
|
Indexed keywords
NEUROLEPTIC AGENT;
KETONE BODY;
BIOLOGICAL MONITORING;
CARDIOVASCULAR DISEASE;
DEPRESSION;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
EXERCISE;
HEREDITY;
HUMAN;
KETOACIDOSIS;
MENTAL DISEASE;
METABOLIC SYNDROME X;
PATHOPHYSIOLOGY;
RISK FACTOR;
SCHIZOPHRENIA;
SHORT SURVEY;
SMOKING;
ACIDOSIS;
ACUTE DISEASE;
BLOOD;
BODY MASS;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
GENETICS;
LIFESTYLE;
MONITORING;
REVIEW;
WORLD HEALTH ORGANIZATION;
ACIDOSIS;
ACUTE DISEASE;
ANTIPSYCHOTIC AGENTS;
BODY MASS INDEX;
DEPRESSIVE DISORDER;
HUMANS;
KETONE BODIES;
LIFE STYLE;
MENTAL DISORDERS;
METABOLIC SYNDROME X;
MONITORING, PHYSIOLOGIC;
RISK FACTORS;
SCHIZOPHRENIA;
SMOKING;
WORLD HEALTH ORGANIZATION;
|
|
EID: 27744512885
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|
